To investigate the mutational profiles of PTPRD or PTPRT in Chinese NSCLC population, a total of 1224 cases of Chinese NSCLC who have undergone 733 cancer gene-panel via next-generation sequencing (NGS) were included in this study, including 886 patients with lung adenocarcinoma and 188 patients with lung squamous cell carcinoma (Table S4). This evidence concerns the gene PTPRD and non-small cell lung carcinoma.